Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Irel13.375 Regulatory News (BOI)

Share Price Information for Bank Irel13.375 (BOI)

Share Price is delayed by 15 minutes
Get Live Data
188.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
BOI Live PriceLast checked at - London Stock Exchange

Intraday Bank Irel13.375 Share Chart

Rule 8.3 - Biotrace Int.

6 Oct 2006 07:00

DKR Ibex Management L.P.05 October 2006 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) DKR IBEX MANAGEMENT L.P. Company dealt in Biotrace International Plc Class of relevant security to which Ordinary shares 10 p the dealings being disclosed relate (Note 2) Date of dealing 05 October 2006 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 60,000 0.15% 0 0.00% (2) Derivatives (other than options) 600,000 1.53% 0 0.00% (3) Options and agreements to 0 0.00% 0 0.00% purchase/sell Total 660,000 1.68% 0 0.00% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 60,000 130.3418 (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) TOTAL RETURN Long 400,000 129.69SWAP CFD Long 200,000 129.69 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. NONE .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 05 October 2006 Contact name Erica Fry Telephone number 203-324-8464 If a connected EFM, name of offeree N/A /offeror with which connected If a connected EFM, state nature of N/A connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Oct 20067:00 amRNSRule 8.3- Biotrace Int.
10th Oct 200610:31 amRNSEPT Disclosure
10th Oct 20067:00 amRNSRule 8.3- Biotrace Int.
9th Oct 20061:30 pmRNSRule 8.3 - Biotrace Int.
9th Oct 200610:49 amRNSEPT Disclosure
6th Oct 20065:59 pmRNSRule 8.1- Biotrace Intl-Amend
6th Oct 20061:26 pmRNSRule 8.3- Biotrace Intl. Plc
6th Oct 200611:54 amRNSEPT Disclosure
6th Oct 200611:00 amRNSEPT Disclosure
6th Oct 200610:58 amRNSEPT Disclosure
6th Oct 200610:55 amRNSOffer Update
6th Oct 200610:52 amRNSRule 8.1- Biotrace Int. PLC
6th Oct 20067:00 amRNSRule 8.3 - Biotrace Int.
5th Oct 200610:26 amRNSEPT Disclosure
4th Oct 20065:34 pmRNSOffer for Biotrace Intl PLC
26th Sep 200610:26 amRNSEPT Disclosure
25th Sep 200610:11 amRNSEPT Disclosure
22nd Sep 200610:38 amRNSEPT Disclosure - Amendment
21st Sep 200610:46 amRNSEPT Disclosure
20th Sep 200610:47 amRNSEPT Disclosure
19th Sep 200610:44 amRNSEPT Disclosure
18th Sep 200611:14 amRNSEPT Disclosure
15th Sep 20068:08 amRNSRule 2.10 Announcement
15th Sep 20067:55 amRNSStatement re Possible Offer
12th Sep 20064:38 pmRNSHolding(s) in Company
6th Sep 20067:01 amRNSInterim Results
14th Aug 20064:25 pmRNSAnnual Information Update
8th Aug 200612:18 pmRNSAnnual Information Update
1st Aug 20067:01 amRNSDirectorate Change
20th Jul 20067:01 amRNSTrading Update
31st May 20067:04 amRNSFinal Results
24th May 200610:23 amRNSHolding(s) in Company
18th May 200612:34 pmRNSHolding(s) in Company
15th May 20067:01 amRNSHolding(s) in Company
11th May 20061:58 pmRNSHolding(s) in Company
11th May 200611:36 amRNSResult of AGM
11th May 20068:02 amRNSAGM Statement
11th May 20067:01 amRNSAGM Statement
11th May 20067:01 amRNSNew Contract
10th May 20062:29 pmRNSAnnual Information Update
21st Apr 20067:00 amRNSCompletion of Property Sale
13th Apr 20065:26 pmRNSHolding(s) in Company
3rd Apr 20067:01 amRNSProperty Disposal
28th Mar 20068:43 amRNSNotifiable Interest
9th Mar 200612:37 pmRNSBlocklisting 6 Monthly Return
8th Mar 20067:04 amRNSAcquisition
1st Mar 20067:02 amRNSPreliminary Results
9th Feb 20067:01 amRNSDisposal of Ruskinn
6th Feb 20061:53 pmRNSHolding(s) in Company
30th Jan 200612:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.